ELAB
PMGC Holdings Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.78
+1.27%Margins
Gross margin
12.7%
EBITDA margin
-1231.4%
EBIT margin
-1250.1%
Net margin
-1306.3%
FCF margin
-1081.6%
-46.1%
Return on equity
-21.1%
Return on assets
-24.1%
Return on invested capital
0.02x
Asset turnover
-$5.9M
Cash from operations
$23
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026